GetMedford Inc.

Cover Block

Name	GetMedford Inc.
Tagline	Online pharma marketplace for authentic meds in Nigeria (B2C/B2B)
Headquarters	Yola, Nigeria
Founded	2023
Stage	Seed
Business Model	Marketplace
Industry	Healthtech
Technology	Software (Non-AI)
Geography	Sub-Saharan Africa
Growth Profile	Venture Scale
Founding Team	Solo Founder
Funding Label	Undisclosed

Links

• Website: https://getmedford.com/
• Google Play: https://play.google.com/store/apps/details?id=com.getmedford.getmedford

What an Investor Needs First

GetMedford is building a dual-sided pharmaceutical marketplace in Nigeria, a bet that directly addresses the twin crises of counterfeit drugs and supply chain fragmentation [Punch Nigeria]. Founded in 2023 by pharmacist Adamu Muhammad, the company connects patients to authentic, affordable medicines via home delivery while also serving hospitals and pharmacies with a B2B bulk procurement platform [Punch Nigeria]. The founding wedge is a supply-side guarantee of authenticity, with the company reporting partnerships exclusively with manufacturers approved by Nigeria's National Agency for Food and Drug Administration and Control (NAFDAC) [Punch Nigeria].

Founder Adamu Muhammad brings over 15 years of healthcare logistics experience from roles at Healthbridge Africa and Helium Health, while co-founder Habibou Moussa provides technical depth as the backend and API specialist [TechParley, Habibou Moussa LinkedIn]. The venture is backed by the pan-African accelerator MEST [F6S]. Early traction includes over 1,200 individual customers and partnerships with more than 100 institutional buyers [Punch Nigeria].

Over the next 12-18 months, the key monitorables are the execution of a stated roadmap to expand into more Nigerian states and the integration of AI-driven demand forecasting.

Data Accuracy: YELLOW -- Key operational metrics and founder background are sourced from a single regional news outlet and founder profiles; independent corroboration is limited.

Inside the Company

GetMedford Inc. was founded in 2023 to address a specific, acute problem in Northern Nigeria: the proliferation of counterfeit and unaffordable medicines [Punch Nigeria]. The company, headquartered in Yola, Nigeria, operates as an online pharmaceutical marketplace, connecting patients and healthcare institutions with verified suppliers [LinkedIn]. Its founding story centers on a pharmacist-entrepreneur, Adamu Muhammad, leveraging over 15 years of experience in healthcare logistics to build a tech-driven solution for supply chain integrity [TechParley].

Within its first year, the company established a dual-sided marketplace, launching both a B2C platform for patient home delivery and a B2B platform for bulk procurement by hospitals and pharmacies [Punch Nigeria]. It secured backing from the pan-African accelerator MEST [F6S]. By the time of its first major press profile, GetMedford reported serving over 1,200 individual customers and partnering with more than 100 hospitals and pharmacies [Punch Nigeria].

Its roadmap includes geographic expansion into more states and plans to integrate AI-driven demand forecasting to optimize inventory [Punch Nigeria].

Data Accuracy: YELLOW -- Company details and milestones are sourced from a single regional press article and accelerator profiles; financials and legal entity are not publicly verified.

Under the Hood

The core product is a dual-sided marketplace. For consumers, GetMedford operates a B2C platform where patients can order authenticated medicines for home delivery [Punch Nigeria]. For institutional buyers, the company provides a B2B platform enabling hospitals and pharmacies to purchase inventory in bulk directly from licensed manufacturers [Punch Nigeria].

The company's primary technical differentiation is a rigorous sourcing and verification protocol, partnering exclusively with manufacturers and distributors approved by NAFDAC [Punch Nigeria]. The public-facing technology includes a consumer-facing mobile application available on Google Play [Google Play] and a web-based procurement portal. The co-founder and CTO's background points to a backend built on Java and Python with a focus on API design and integration [Habibou Moussa LinkedIn].

The company states it has served over 1,200 individual customers and partnered with more than 100 hospitals and pharmacies [Punch Nigeria].

Data Accuracy: YELLOW -- Product claims are consistent across the company's website and a single press article. Traction metrics are company-sourced and not independently verified. Technical stack details are inferred from founder profiles.

Market Research

The Nigerian pharmaceutical market is defined by a fundamental tension between a massive, growing demand for medicine and a fragmented, unreliable supply chain. A 2023 report by the research firm Briter Bridges estimated the total value of Africa's pharmaceutical market at $45 billion, with Nigeria accounting for a significant portion [Briter Bridges, 2023]. The World Health Organization has highlighted that sub-Saharan Africa bears the highest burden of substandard and falsified medical products, with Nigeria frequently cited as a major market for such goods [WHO].

Demand is propelled by a large, young population and the rise of chronic non-communicable diseases like hypertension and diabetes. The company's cited partnership with over 100 hospitals and pharmacies suggests it is initially targeting institutional bulk buyers [Punch Nigeria]. GetMedford's claim to partner exclusively with NAFDAC-approved manufacturers is a direct response to the regulatory environment [Punch Nigeria].

Metric	Value
Africa Pharma Market (2023 est.)	$45B

Data Accuracy: YELLOW -- Market sizing is inferred from analogous regional reports, not company-specific analysis. Traction claims are sourced from a single regional news outlet.

Competition and Substitutes

GetMedford enters a Nigerian pharmaceutical supply chain defined by fragmentation and inefficiency.

Company	Positioning	Stage / Funding	Notable Differentiator
GetMedford	B2C/B2B online marketplace for authentic medicines in Nigeria.	Seed; Accelerated by MEST.	Dual B2C/B2B model; NAFDAC-approved supply chain integrity.
DrugStoc	B2B pharmaceutical marketplace connecting manufacturers to healthcare providers.	Venture-backed; $4.4M Series A (2022).	Focused exclusively on the B2B institutional segment.
Lifestores Pharmacy	Omnichannel pharmacy platform operating retail stores and an online marketplace.	Venture-backed; $3M pre-Series A (2022).	Integrated offline retail footprint with online presence.

GetMedford's edge rests on its simultaneous pursuit of both B2C and B2B customers and its emphasis on partnering exclusively with NAFDAC-approved manufacturers [Punch Nigeria]. It lacks the institutional funding and scale of its named competitors and does not currently own physical last-mile assets.

Data Accuracy: YELLOW -- Competitor profiles and funding stages are confirmed via Crunchbase. GetMedford's positioning is sourced from a single regional press article [Punch Nigeria].

Opportunity

If GetMedford can reliably connect Nigeria's fragmented pharmaceutical supply chain, the prize is a dominant marketplace serving a population of over 200 million people. The company is positioning itself as essential infrastructure that addresses a public health crisis [Punch Nigeria]. Early traction, cited as over 1,200 individual customers and partnerships with more than 100 hospitals and pharmacies, demonstrates initial proof of a fragmented market willing to transact on a centralized platform [Punch Nigeria].

Scenario	What happens	Catalyst	Why it's plausible
B2B Anchor Expansion	GetMedford becomes the primary bulk procurement partner for its existing network.	Securing a strategic partnership or dedicated supply agreement.	The company's stated model is built on direct manufacturer relationships [Punch Nigeria].
Geographic Dominance in the North	The company achieves market leadership in Northern Nigeria.	Successful rollout of the logistics network.	The founder's 15+ years in healthcare logistics provides domain expertise [TechParley].
AI-Driven Supply Orchestration	GetMedford evolves from a marketplace to a predictive supply chain platform.	Integration of AI-driven demand forecasting tools.	The accumulation of transactional data creates a proprietary dataset [Punch Nigeria].

Data Accuracy: YELLOW -- Traction and partnership metrics are sourced from a single regional news outlet. Founder background and product claims have partial corroboration across multiple sources.

Sources

1. [Punch Nigeria] GetMedford deploys tech to boost genuine medicines access | https://punchng.com/getmedford-deploys-tech-to-boost-genuine-medicines-access/
2. [TechParley] Adamu Muhammad’s GetMedford Tackles Nigeria’s Counterfeit Medicine Crisis with Tech | https://techparley.com/adamu-muhammads-getmedford-tackles-nigerias-counterfeit-medicine-crisis-with-tech/
3. [F6S] Adamu Muhammad profile | https://www.f6s.com/adamu-muhammad
4. [LinkedIn] Habibou Moussa - Co-founder & CTO at GetMedford Inc | https://www.linkedin.com/in/habibou-moussa/
5. [Google Play] Getmedford - Apps on Google Play | https://play.google.com/store/apps/details?id=com.getmedford.getmedford
6. [Crunchbase] DrugStoc Company Profile & Funding | https://www.crunchbase.com/organization/drugstoc
7. [Crunchbase] Lifestores Pharmacy Company Profile & Funding | https://www.crunchbase.com/organization/lifestores-pharmacy
8. [Briter Bridges, 2023] Africa's Pharmaceutical Market Report | https://briterbridges.com/reports